These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11784512)

  • 1. [Should Helicobacter pylori infection be treated prior to long-term proton pump inhibitor therapy?].
    Gisbert JP; Pajares JM
    Med Clin (Barc); 2001 Dec; 117(20):793-7. PubMed ID: 11784512
    [No Abstract]   [Full Text] [Related]  

  • 2. [Guidelines for the management of Helicobacter pylori--Maastricht III-2005 and Japanese guidelines].
    Kodama M; Murakami K; Okimoto T; Fujioka T
    Nihon Rinsho; 2008 Apr; 66(4):804-10. PubMed ID: 18409534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Helicobacter pylori Infection in the Proton Pump Inhibitor Era.
    Calvet X
    Gastroenterol Clin North Am; 2015 Sep; 44(3):507-18. PubMed ID: 26314665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor for treatment of Helicobacter pylori in patients with chronic renal failure: is it necessary?
    Xu G; Li J; Cheng P; Tu W
    Med Princ Pract; 2011; 20(1):100. PubMed ID: 21160225
    [No Abstract]   [Full Text] [Related]  

  • 5. Rationale for a Helicobacter pylori Test and Treatment Strategy in Gastroesophageal Reflux Disease.
    Vakil N
    Gastroenterol Clin North Am; 2015 Sep; 44(3):661-6. PubMed ID: 26314675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. By the way, doctor. I was treated for two weeks with antibiotics and a proton pump inhibitor when I had an H.pylori infection. I've continued with the proton inhibitor to cut down on stomach acid. Could that be harmful?
    Komaroff AL
    Harv Health Lett; 2008 Jul; 33(9):8. PubMed ID: 18777657
    [No Abstract]   [Full Text] [Related]  

  • 7. Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
    Tanabe H; Yoshino K; Ando K; Nomura Y; Ohta K; Satoh K; Ichiishi E; Ishizuka A; Otake T; Kohgo Y; Fujiya M; Okumura T
    Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):29. PubMed ID: 29950163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can proton pump inhibitors be used as bactericidal drugs in Helicobacter pylori-positive patients?
    Saito N; Sato F; Oda H; Takeda H; Kato M; Sugiyama T; Rani A; Asaka M
    Helicobacter; 1999 Sep; 4(3):211-2. PubMed ID: 10469196
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Helicobacter pylori infection].
    Kim JG
    Korean J Gastroenterol; 2005 Sep; 46(3):172-80. PubMed ID: 16179836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection.
    Hunt R; Fallone C; Veldhuyzan van Zanten S; Sherman P; Smaill F; Flook N; Thomson A;
    Can J Gastroenterol; 2004 Sep; 18(9):547-54. PubMed ID: 15457293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.
    Fallone CA; Chiba N; van Zanten SV; Fischbach L; Gisbert JP; Hunt RH; Jones NL; Render C; Leontiadis GI; Moayyedi P; Marshall JK
    Gastroenterology; 2016 Jul; 151(1):51-69.e14. PubMed ID: 27102658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Errors in a meta-analysis of treatments for Helicobacter pylori infection.
    Gatta L; Di Mario F; Zullo A; Vaira D
    Ann Intern Med; 2008 Nov; 149(9):686; author reply 686. PubMed ID: 18981492
    [No Abstract]   [Full Text] [Related]  

  • 13. Does pretreatment with proton pump inhibitors influence the eradication rate of Helicobacter pylori?
    Tokoro C; Inamori M; Koide T; Iida H; Sakamoto Y; Endo H; Hosono K; Takahashi H; Yoneda M; Yasuzaki H; Ogawa M; Abe Y; Kubota K; Saitou S; Kawana I; Matsuda R; Takahashi D; Nakajima A
    Hepatogastroenterology; 2010; 57(104):1645-9. PubMed ID: 21443136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroesophageal reflux disease and the relationship with Helicobacter pylori.
    Mungan Z; Pınarbaşı Şimşek B
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S61-S67. PubMed ID: 29199171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The several problems and cautions in treatment of Helicobacter pylori infection].
    Fukuda Y; Sakagami T
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1465-74. PubMed ID: 15508434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Helicobacter pylori eradication: best treated for 14 days].
    Riemann JF
    Dtsch Med Wochenschr; 2014 Apr; 139(15):764. PubMed ID: 24691687
    [No Abstract]   [Full Text] [Related]  

  • 18. Proton pump inhibitors and Helicobacter pylori gastritis: friends or foes?
    Kuipers EJ
    Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):187-94. PubMed ID: 16930292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors and helicobacter pylori-associated pathogenesis.
    Hagiwara T; Mukaisho K; Nakayama T; Hattori T; Sugihara H
    Asian Pac J Cancer Prev; 2015; 16(4):1315-9. PubMed ID: 25743791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
    Sasakii M; Joh T; Yokoyama Y; Seno K; Tsuchida K; Kurokawa T; Itoh M
    J Pharm Pharmacol; 1999 Jul; 51(7):825-30. PubMed ID: 10467958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.